Phase III Study of TS-142 in Patients with Insomnia
NCT05453136
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1155
Enrollment
INDUSTRY
Sponsor class
Conditions
Patients with Insomnia
Interventions
DRUG:
TS-142 5 mg
DRUG:
TS-142 10 mg
DRUG:
Placebo to TS-142
Sponsor
Taisho Pharmaceutical Co., Ltd.